Suven Pharmaceuticals Share Price
Know More₹1,160.00 32.85 (2.91%)
16:01 PM, 12-Mar-2025BSE : 543064
NSE : SUVENPHAR
Sector : Health care
ISIN Code : INE03QK01018
- BSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: 12-Mar-2025 | 04:01 PM IST
| Market Cap (₹ Cr) | 29,534 |
Traded Value (₹ Cr) | 0.41 |
Volume (Shares) | 3,553 |
Face Value (₹) | 1 |
52-Week High (₹) | 1,359.00 |
52-Week High Date | 02-Dec-2024 |
52-Week Low (₹) | 597.00 |
52-Week Low Date | 04-Jun-2024 |
All Time High (₹) | 1,359.00 |
All Time High Date | 02-Dec-2024 |
All Time Low (₹) | 87.05 |
All Time Low Date | 24-Mar-2020 |
Suven Pharmaceuticals Ltd
Suven Pharmaceuticals Ltd News
Suven Pharma Announcement
Suven Pharmaceuticals Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 29,534 |
| EPS - TTM (₹) [C] | 10.97 |
| P/E Ratio (X) [C] | 105.74 |
| Face Value (₹) | 1 |
| Latest Dividend (%) | 100.00 |
| Latest Dividend Date | 09-Sep-2022 |
| Dividend Yield (%) | - |
| Book Value Share (₹) [C] | 77.71 |
| P/B Ratio (₹) [C] | 14.93 |
Funds Owning this Stock
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| Tata Small Cap Fund - Direct (IDCW) RI | 161.43 | 13,29,000 | 1.95 |
| Tata Small Cap Fund - Regular (IDCW) RI | 161.43 | 13,29,000 | 1.95 |
| Tata Small Cap Fund - Direct (IDCW) | 161.43 | 13,29,000 | 1.95 |
| Tata Small Cap Fund - Direct (G) | 161.43 | 13,29,000 | 1.95 |
| Tata Small Cap Fund - Regular (IDCW) | 161.43 | 13,29,000 | 1.95 |
| Tata Small Cap Fund - Regular (G) | 161.43 | 13,29,000 | 1.95 |
| SBI Healthcare Opportunities Fund (IDCW) | 65.67 | 5,40,604 | 1.98 |
| SBI Healthcare Opportunities Fund (G) | 65.67 | 5,40,604 | 1.98 |
| SBI Healthcare Opportunities Fund - Direct (G) | 65.67 | 5,40,604 | 1.98 |
| SBI Healthcare Opportunities Fund - Direct (IDCW) | 65.67 | 5,40,604 | 1.98 |
Load more
Research Reports
Stock Strength
| Today's Low/High (₹) | 1,129.00 1,162.45 |
| Week Low/High (₹) | 485.30 1,162.45 |
| Month Low/High (₹) | 481.30 1,162.45 |
| Year Low/High (₹) | 597.00 1,359.00 |
| All time Low/High (₹) | 87.05 1,359.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | 136.11% | 135.31% | 22.97% | 27.64% |
| 1 Month | 134.96% | 134.74% | 19.03% | 23.24% |
| 3 Month | 177.74% | 177.85% | 19.93% | 24.47% |
| 6 Month | 146.86% | 145.90% | 25.04% | 29.23% |
| 1 Year | 109.25% | 109.13% | 24.11% | 27.96% |
| 3 Year | - | - | 82.98% | 91.93% |
Company Info
Company Information
Independent Director : Deepanwita Chattopadhyay
Registered Office: 8-2-334 SDE Serene Chambers, 3 Floor Avenue 7 Road No 5,Hyderabad,Telangana-500034 Ph: 91-40-23549414/1142/3311
Email:info@suvenpharm.com
FAQs about Suven Pharmaceuticals Ltd
1. What's the Suven Pharmaceuticals Ltd share price today?
Suven Pharmaceuticals Ltd share price was Rs 1,160.00 at 16:01 PM IST on 12th Mar 2025. Suven Pharmaceuticals Ltd share price was up by 2.91% over the previous closing price of Rs 1,127.15. Suven Pharmaceuticals Ltd share price trend:
- Last 1 Month: Suven Pharmaceuticals Ltd share price moved up by 134.96% on BSE.
- Last 3 Months: Suven Pharmaceuticals Ltd share price moved up by 177.74% on BSE.
- Last 12 Months: Suven Pharmaceuticals Ltd share price moved up by 109.25% on BSE.
2. How can I quickly analyse the performance of the Suven Pharmaceuticals Ltd stock?
The performance of the Suven Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:
- The stock's PE is 105.74
- Price to book value ratio is 14.93
- The EPS (trailing 12 months) of the Suven Pharmaceuticals Ltd stock is Rs 10.97
3. What is the market cap of Suven Pharmaceuticals Ltd?
Suven Pharmaceuticals Ltd has a market capitalisation of Rs 29,534 crore.
4. What is Suven Pharmaceuticals Ltd's 52-week high/low share price?
The Suven Pharmaceuticals Ltd’s 52-week high share price is Rs 1,359.00 and 52-week low share price is Rs 597.00.
5. Is the Suven Pharmaceuticals Ltd profitable?
On a consolidated basis, Suven Pharmaceuticals Ltd reported a profit of Rs 83.29 crore on a total income of Rs 322.86 crore for the quarter ended 2024. For the year ended 2024, Suven Pharmaceuticals Ltd had posted a profit of Rs 300.28 crore on a total income of Rs 1,051.35 crore.
6. Which are Suven Pharmaceuticals Ltd’s peers in the Health care sector?
Suven Pharmaceuticals Ltd’s top 5 peers in the Health care sector are Ipca Labs., Ajanta Pharma, Laurus Labs, Suven Pharma, Piramal Pharma, Gland Pharma, J B Chemicals &.
7. Who owns how much in Suven Pharmaceuticals Ltd?
Key changes to the Suven Pharmaceuticals Ltd shareholding are as follows:
- Promoter holding in Suven Pharmaceuticals Ltd has gone up to 60.00 per cent as of Dec 2022 from 60.00 per cent as of Mar 2022.
